A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
A Phase I/II Trial of AEZS-108 in Locally Advanced Unresectable or Metastatic Luteinizing Hormone-releasing Hormone(LHRH) Positive Urothelial Carcinoma Patients Who Failed Platinum Based Chemotherapy
Sponsor: AEterna Zentaris
Terminated
Poor recruitment
Other terminated trials from AEterna Zentaris
Other Urothelial Carcinoma trials with similar outcome
A PHASE1/PHASE2 clinical study on Urothelial Carcinoma, this trial is terminated or withdrawn. The trial is conducted by AEterna Zentaris and has accumulated 9 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Apr 2022 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
-
Jan 2021 — Apr 2022 [monthly]
Terminated PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE1_PHASE2
▶ Show 4 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated PHASE1_PHASE2
-
Mar 2018 — Apr 2018 [monthly]
Terminated PHASE1_PHASE2
-
Feb 2017 — Mar 2018 [monthly]
Terminated PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1_PHASE2
First recorded
Nov 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AEterna Zentaris
- Miami VA Healthcare System
- University of Miami
- University of Miami Sylvester Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .